Cargando…
Discovery of a series of novel phenylpiperazine derivatives as EGFR TK inhibitors
Human epidermal growth factor receptor (EGFR) is an important drug target that plays a fundamental role in signal transduction pathways in oncology. We report herein the discovery of a novel class of phenylpiperazine derivatives with improved potency toward EGFR. The biological activity of compound...
Autores principales: | Sun, Juan, Wang, Xin-Yi, Lv, Peng-Cheng, Zhu, Hai-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4563558/ https://www.ncbi.nlm.nih.gov/pubmed/26349898 http://dx.doi.org/10.1038/srep13934 |
Ejemplares similares
-
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
por: Saleh, Nashwa M., et al.
Publicado: (2020) -
Synthesis and acaricidal activity of phenylpiperazine derivatives
por: Suzuki, Jun, et al.
Publicado: (2021) -
Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
por: Sun, Shaofeng, et al.
Publicado: (2017) -
A New Series of Indeno[1,2-c]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy
por: Özdemir, Ahmet, et al.
Publicado: (2022) -
Evaluation of phenylpiperazines as targeting agents for neuroblastoma.
por: Babich, J. W., et al.
Publicado: (1996)